GOLETA, Calif.–(BUSINESS WIRE)–Inogen, Inc. (Nasdaq: INGN), a medical expertise firm providing progressive respiratory merchandise to be used within the homecare setting, at present introduced it has entered right into a strategic collaboration with Jiangsu Yuyue Medical (TASE:) Gear & Provide Co., Ltd. (002223.SZ, Yuwell), a world residence healthcare medical machine producer with a complete portfolio of respiratory merchandise.
The strategic collaboration is predicted to broaden Inogen (NASDAQ:)’s product portfolio via distribution of sure respiratory merchandise in the US and choose different territories, broaden and improve Inogen’s innovation pipeline via R&D collaboration, and speed up the entry of Inogen’s model into the Chinese language market. As well as, Yuwell, via its affiliate, has agreed to take a position roughly $27.2 million in Inogen, representing a 9.9% widespread fairness curiosity, additional cementing the collaboration and bolstering Inogen’s steadiness sheet.
The collaboration with Yuwell is a pivotal step in accelerating Inogen’s progress trajectory. By increasing our product portfolio, international presence and enhancing our innovation pipeline, we count on to be well-positioned to seize new market alternatives, stated Kevin Smith, President and Chief Government Officer. This collaboration helps our dedication to delivering long-term worth to our shareholders and reinforces our imaginative and prescient of creating Inogen as a platform for best-in-class respiratory options for sufferers throughout the globe. We’re assured that our collaboration with Yuwell will play an important function in our continued success.”
Alex Wu, Chairman of Yuwell, added, Inogen is a frontrunner within the respiratory remedy market and our strategic collaboration gives each events with the flexibility to broaden their geographic attain and additional meet affected person wants the world over. Yuwell shares Inogen’s dedication to growing and offering progressive, high quality merchandise and we imagine that collectively we are able to make a significant distinction within the lives of respiratory sufferers. Collectively, Yuwell and Inogen purpose to outline the following era of respiratory merchandise.
The collaboration settlement will grow to be efficient instantly, whereas the acquisition of the fairness from Inogen is predicted to shut through the first quarter of 2025, topic to sure customary closing situations.
About Inogen
Inogen, Inc. (Nasdaq: INGN) is a number one international medical expertise firm providing progressive respiratory merchandise to be used within the homecare setting. Inogen helps affected person respiratory care by growing, manufacturing, and advertising progressive best-in-class respiratory remedy units used to ship care to sufferers affected by continual respiratory situations. Inogen companions with sufferers, prescribers, residence medical gear suppliers, and distributors to make its respiratory remedy merchandise extensively accessible, permitting sufferers the prospect to handle the affect of their illness.
For extra data, please go to www.inogen.com.
Inogen has used, and intends to proceed to make use of, its Investor Relations web site, http://investor.inogen.com/, as a way of exposing materials personal data and for complying with its disclosure obligations underneath Regulation FD.
About Yuwell
Since its institution in 1998, Yuwell has been on the forefront of offering cutting-edge medical machine options to boost affected person care and enhance residence healthcare worldwide. Yuwell (002223.SZ) generated over US $1 billion income in 2023, and has a broad product portfolio throughout respiratory remedy, diabetes administration, digital diagnostics merchandise, first assist options and rehabilitation, amongst different areas.
With a steadfast dedication to medical excellence, Yuwell delivers high-quality, medically dependable merchandise that empower healthcare professionals to realize superior affected person outcomes.
With 9 state-of-the-art R&D facilities and seven superior manufacturing amenities, Yuwell’s international presence spans over 100 nations and helps greater than 300,000 healthcare establishments. Yuwell touches the lives of sufferers across the globe by bringing skilled, user-friendly medical units into the house.
Ahead-Trying Statements
This press launch incorporates forward-looking statements throughout the that means of the Personal Securities Litigation Reform Act of 1995. All statements contained on this communication that aren’t historic info, together with, however not restricted to, statements relating to Inogen’s future enterprise plans, market alternatives, monetary outlook, progress methods, and anticipated operational outcomes, are forward-looking statements. Phrases equivalent to goals, believes, anticipates, plans, expects, will, intends, potential, doable, and related expressions are meant to determine forward-looking statements. Ahead-looking statements are topic to quite a few dangers and uncertainties that would trigger precise outcomes to vary materially from at present anticipated outcomes, together with however not restricted to, dangers and uncertainties regarding the potential advantages of Inogen’s collaboration with Yuwell; satisfaction of the closing situations underneath the securities buy settlement regarding the fairness funding; the timing of closing of the fairness funding; market acceptance of its merchandise; competitors; its gross sales, advertising and distribution capabilities; its deliberate gross sales, advertising, and analysis and growth actions; and dangers related to worldwide operations. For an in depth dialogue of those and different dangers that would affect Inogen’s operations and monetary efficiency, please discuss with the Danger Components part of its Annual Report on Type 10-Okay for the interval ended December 31, 2023, its Quarterly Report on Type 10-Q for the calendar quarter ended March 31, 2024 and in its different filings with the Securities and Alternate Fee. These forward-looking statements communicate solely as of the date hereof. Inogen disclaims any obligation to replace these forward-looking statements besides as could also be required by legislation.
View supply model on businesswire.com: https://www.businesswire.com/information/residence/20250126900450/en/
ir@inogen.web
Supply: Inogen, Inc.
